6HMD
STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA'; CSNK2A2 gene product) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR AR18
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE BM30A |
Synchrotron site | ESRF |
Beamline | BM30A |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2017-11-23 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.920042 |
Spacegroup name | P 1 |
Unit cell lengths | 44.890, 45.820, 48.520 |
Unit cell angles | 113.02, 89.21, 91.18 |
Refinement procedure
Resolution | 22.327 - 1.000 |
R-factor | 0.1496 |
Rwork | 0.149 |
R-free | 0.17180 |
Structure solution method | AB INITIO PHASING |
RMSD bond length | 0.022 |
RMSD bond angle | 1.317 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | Arcimboldo |
Refinement software | PHENIX ((1.13_2998: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 44.880 | 1.036 |
High resolution limit [Å] | 1.000 | 1.000 |
Rmerge | 0.047 | 1.028 |
Rmeas | 0.055 | 1.189 |
Rpim | 0.028 | 0.597 |
Number of reflections | 177359 | 17032 |
<I/σ(I)> | 15.67 | 1.36 |
Completeness [%] | 92.2 | 88.55 |
Redundancy | 3.9 | 4 |
CC(1/2) | 0.999 | 0.557 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 293.15 | 180 MICROLITER ENZYME STOCK SOLUTION (6 MG/ML IN 500 MM NACL, 25 MM TRIS/HCL, PH 8.5) WAS MIXED and incubated WITH 20 MIKROLITER of a STOCK SOLUTION of the inhibitor 4B0 (10 MM 4B0 IN DMSO). 20 MICROLITERS OF the resulting solution WAS MIXED WITH 10 MICROLITERS OF RESERVOIR SOLUTION (700 MM LICL, 28 % (W/V) PEG 6000, 100 MM TRIS/HCL, PH 8.5) IN EACH WELL OF A CRYSTALLIZATION PLATE. A SINGLE MACROSEED, grown UNDER THE SAME CONDITIONS, WAS ADDED TO EACH DROPLET of the plate. THE DROPLETS WERE EQUILIBRATED AT 293.15 K using the sitting drop variant of the VAPOR DIFFUSION method. This procedure generated large single crystals of a CK2alpha'/4B0 complex. Afterwards, the inhibitor 4B0 was exchanged against AR18 by an extensive soaking procedure of several steps. |